Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (241-250 of 300) with videos related to

Pageof 30
Sort By:
Plos Neglected Tropical Diseases|May 9, 2017
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccinationStephen S Whitehead, Anna P Durbin, Kristen K Pierce, et al.
Ejhaem|May 23, 2022
Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial modelConor McCafferty, Leo Lee, Tengyi Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Science Immunology|August 6, 2017
Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responsesJingxian Zhao, Abeer N Alshukairi, Salim A Baharoon, et al.
The Journal of Infection|March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in AustraliaNadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Mbio|July 21, 2022
Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory ExerciseJessica A Belser, Eric H Y Lau, Wendy Barclay, et al.
Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.
Research Square|October 7, 2024
Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohortSheena Sullivan, Arseniy Khvorov, Louise Carolan, et al.
The Journal of Infection|February 20, 2025
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth doseNadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Journal of Virology|February 16, 2018
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph NodesSinthujan Jegaskanda, Rosemarie D Mason, Sarah F Andrews, et al.
Pageof 30

Showing results (241-250 of 300) with videos related to

Sort By:
Pageof 30
Plos Neglected Tropical Diseases|May 9, 2017
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccinationStephen S Whitehead, Anna P Durbin, Kristen K Pierce, et al.
Ejhaem|May 23, 2022
Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial modelConor McCafferty, Leo Lee, Tengyi Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Science Immunology|August 6, 2017
Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responsesJingxian Zhao, Abeer N Alshukairi, Salim A Baharoon, et al.
The Journal of Infection|March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in AustraliaNadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Mbio|July 21, 2022
Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory ExerciseJessica A Belser, Eric H Y Lau, Wendy Barclay, et al.
Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.
Research Square|October 7, 2024
Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohortSheena Sullivan, Arseniy Khvorov, Louise Carolan, et al.
The Journal of Infection|February 20, 2025
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth doseNadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Journal of Virology|February 16, 2018
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph NodesSinthujan Jegaskanda, Rosemarie D Mason, Sarah F Andrews, et al.
Pageof 30